Ariel Brown

Sep 30, 2024 | opmed.doximity.com | Ariel Brown |Jiwon V. Park |Miguel Angel Villagra-Diaz |Kymberley Armstrong

Is Humanity Lost in Moments of Trauma? It’s one thing to make the choice to spend your career fighting to save lives; it’s another thing altogether to come face-to-face with the harsh reality of death. As a third-year medical student, my trauma surgery rotation highlighted that distinction. For all the patients we saved, there were also those who, despite the team’s best efforts, succumbed to their injuries amid trauma activations.

Aug 30, 2024 | kevinmd.com | Ariel Brown |Michelle Ikoma |Scott Landman |Nicholas Bellacicco

It’s one thing to choose a career dedicated to saving lives; it’s another altogether to confront the harsh reality of death. As a third-year medical student, my trauma surgery rotation highlighted that distinction. For all the patients we saved, there were also those who, despite the team’s best efforts, succumbed to their injuries amidst trauma activations.

Jul 9, 2024 | onlinelibrary.wiley.com | Ariel Brown |Andrew Park |Nnenna G. Agim |Katherine Gordon

1 INTRODUCTION Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), blistering skin and mucosal eruptions, remain ill-defined in pediatric patients.1 Though guidelines exist, much data are still needed to optimize patient care.2 Emerging new classification for SJS/TEN caused by drugs simplifies clinical diagnostic criteria into a single diagnosis, “drug-induced epidermal necrolysis” (DEN).3 In this report, when SJS/TEN are grouped, the terminology DEN will be used.

Jun 4, 2024 | dialnet.unirioja.es | Sophia N. Wix |M Phil |Ariel Brown |Meghan M. Heberton

Clinical Features and Outcomes of Black Patients With MelanomaAutores: Sophia N. Wix, M Phil, Ariel B. Brown, Meghan Heberton, Adewole S. Adamson, Jennifer G. GillLocalización: JAMA Dermatology, ISSN 2168-6068, Vol. 160, Nº. 3, 2024, págs. 328-333Idioma: inglésTexto completo no disponible (Saber más ...)ResumenMelanoma in Black individuals has an annual incidence of approximately 1 in 100 000 people.

Jan 24, 2024 | jamanetwork.com | Sophia N. Wix |Ariel Brown |Meghan M. Heberton |Jennifer Gill

Key PointsQuestion  What characteristics are associated with melanoma development and poor outcomes in Black patients? Findings  In this single-institution case series of 48 Black patients with melanoma, 75% of cutaneous melanomas occurred on acral skin; nonacral cutaneous melanomas were seen more often in patients who were immunocompromised and/or had a personal history of other cancers.